S H Advani

855 total citations
50 papers, 616 citations indexed

About

S H Advani is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S H Advani has authored 50 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 13 papers in Molecular Biology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S H Advani's work include Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). S H Advani is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). S H Advani collaborates with scholars based in India, United States and Australia. S H Advani's co-authors include HG Ahuja, Swati Pai, Steven L. Allen, John M. Goldman, Menashe Bar‐Eli, D. Snyder, A Foti, M J Cline, Z Arlin and C. N. Nair and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Oncology and Journal of Hospital Infection.

In The Last Decade

S H Advani

48 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S H Advani India 15 261 162 156 141 137 50 616
Sam Penza United States 17 467 1.8× 321 2.0× 134 0.9× 88 0.6× 103 0.8× 63 806
Steve Andresen United States 12 289 1.1× 183 1.1× 64 0.4× 140 1.0× 69 0.5× 30 524
Vaneuza Araújo Moreira Funke Brazil 14 431 1.7× 176 1.1× 111 0.7× 130 0.9× 120 0.9× 61 646
Reggie Duerst United States 17 414 1.6× 213 1.3× 168 1.1× 112 0.8× 96 0.7× 42 902
BJ Bolwell United States 13 383 1.5× 331 2.0× 111 0.7× 74 0.5× 73 0.5× 19 685
R. Or Israel 16 698 2.7× 267 1.6× 130 0.8× 101 0.7× 68 0.5× 48 1.0k
Peter Schauer United States 11 115 0.4× 218 1.3× 168 1.1× 89 0.6× 82 0.6× 13 629
Ivetta Danylesko Israel 17 495 1.9× 299 1.8× 173 1.1× 114 0.8× 149 1.1× 67 842
Karin Kolbe Germany 22 759 2.9× 465 2.9× 202 1.3× 146 1.0× 162 1.2× 53 1.2k
Peter Waldron United States 13 169 0.6× 117 0.7× 49 0.3× 145 1.0× 155 1.1× 30 641

Countries citing papers authored by S H Advani

Since Specialization
Citations

This map shows the geographic impact of S H Advani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S H Advani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S H Advani more than expected).

Fields of papers citing papers by S H Advani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S H Advani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S H Advani. The network helps show where S H Advani may publish in the future.

Co-authorship network of co-authors of S H Advani

This figure shows the co-authorship network connecting the top 25 collaborators of S H Advani. A scholar is included among the top collaborators of S H Advani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S H Advani. S H Advani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Connelly, Kim A., Andrew Advani, S H Advani, et al.. (2011). Combination Angiotensin Converting Enzyme and Direct Renin Inhibition in Heart Failure following Experimental Myocardial Infarction. Cardiovascular Therapeutics. 31(2). 84–91. 12 indexed citations
2.
Naresh, Kikkeri N., S H Advani, Melissa Adde, et al.. (2004). Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries. Blood Cells Molecules and Diseases. 33(3). 330–337. 36 indexed citations
3.
Chinoy, Roshan F., et al.. (1999). METASTATIC OVARIAN NEUROBLASTOMA: A Case Report. Pediatric Hematology and Oncology. 16(5). 459–462. 4 indexed citations
4.
Bapna, Ajay, et al.. (1998). All-Trans-Retinoic Acid (ATRA): Pediatric Acute Promyelocytic Leukemia. Pediatric Hematology and Oncology. 15(3). 243–248. 23 indexed citations
5.
Saika, Shizuya, et al.. (1998). L-Asparaginase (Leunase) Induced Pancreatitis in Childhood Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology. 15(6). 533–538. 34 indexed citations
6.
Parikh, Purvish M., et al.. (1996). Incidence of 5′ bcl-2 rearrangement in patients with B cell chronic lymphocytic leukemia from India. Leukemia Research. 20(9). 791–793. 2 indexed citations
7.
Parikh, Purvish M., et al.. (1995). Unusually Prominent M Protein in Indian Patients with IgD Multiple Myeloma. Acta Haematologica. 94(4). 216–217.
8.
Advani, S H, et al.. (1994). Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma. Medical and Pediatric Oncology. 22(2). 125–128. 21 indexed citations
9.
Nair, C. N., et al.. (1994). Use of polyclonal anti-myeloperoxidase antibody in myeloid lineage determination.. PubMed. 100. 272–6. 3 indexed citations
10.
Bhatia, Karishma, G Spangler, S H Advani, et al.. (1993). MOLECULAR CHARACTERIZATION OF SCL REARRANGEMENTS IN T-CELL ALL FROM INDIA AND EGYPT. International Journal of Oncology. 2(5). 725–30. 5 indexed citations
11.
Ahuja, HG, Menashe Bar‐Eli, Z Arlin, et al.. (1991). The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.. Journal of Clinical Investigation. 87(6). 2042–2047. 146 indexed citations
12.
Advani, S H, et al.. (1991). Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia. Cancer Genetics and Cytogenetics. 51(2). 167–181. 19 indexed citations
13.
Merchant, Akil, et al.. (1990). Cytogenetic findings in patients with acute promyelocytic leukemia and a case of CML blast crisis with promyelocytic proliferation. Cancer Genetics and Cytogenetics. 50(1). 109–117. 18 indexed citations
14.
Shirsat, Neelam, Surekha M. Zingde, S H Advani, & B.P. Gothoskar. (1989). The receptor for IgG on human normal and chronic myeloid leukemic granulocytes: functional and biochemical characterization.. PubMed. 10(3). 235–45. 6 indexed citations
15.
Advani, S H, et al.. (1989). Induction chemotherapy in head and neck cancer: Present status and future. Seminars in Surgical Oncology. 5(5). 337–340. 1 indexed citations
16.
Gordon, Sharon M., Neelam Giri, Gopalakrishnan Ramakrishnan, et al.. (1989). Epidemic iatrogenic Acinetobacter spp. meningitis following administration of intrathecal methotrexate. Journal of Hospital Infection. 14(3). 233–243. 19 indexed citations
17.
Chitnis, M.P., et al.. (1988). Modulation of Sensitivity to Mitoxantrone in Human Chronic Myeloid Leukemia Cells by the Antidepressant Sintamil. Oncology. 45(4). 292–296. 6 indexed citations
18.
Advani, S H, et al.. (1987). Acquired immunodeficiency syndrome--a study of two case reports with manifest HIV infection.. PubMed. 35(6). 454–7. 3 indexed citations
19.
Advani, S H, et al.. (1984). Vertebral involvement in childhood acute lymphoblastic leukemia. The Indian Journal of Pediatrics. 51(1). 103–107. 2 indexed citations
20.
Gopal, R., et al.. (1981). Herpes-zoster in malignancy.. PubMed. 28(5-6). 125–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026